{
  "schemaVersion": "2.0.0",
  "identity": {
    "slug": "livanova-sentiva",
    "manufacturerSlug": "livanova",
    "name": {
      "value": "LivaNova SenTiva",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "modelNumber": {
      "value": "Model 1000",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "codename": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "aliases": {
      "value": [
        "SenTiva",
        "Cyberonics SenTiva",
        "VNS Therapy SenTiva"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "generation": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "predecessorSlug": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "successorSlug": {
      "value": "livanova-sentiva-duo",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.medicaldevice-network.com/news/livanova-sentiva-duo-epilepsy/",
          "label": "Medical Device Network — LivaNova launches SenTiva DUO (2023-02-06)",
          "date": "2023-02-06"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "tagline": {
      "status": "unknown",
      "sources": [
        {
          "label": "editorial copy — not a sourced fact"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "shortDescription": {
      "status": "unknown",
      "sources": [
        {
          "label": "editorial prose — not a sourced fact"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "longDescription": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "countryOfOrigin": {
      "value": "US",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "releaseDate": {
      "value": "2017-10",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "announcedDate": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "discontinuedDate": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "status": {
      "value": "shipping",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "classification": {
    "invasiveness": {
      "value": "invasive",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "modalities": {
      "value": [
        "VNS"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "primaryModality": {
      "value": "VNS",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "direction": {
      "value": "read-write",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "category": {
      "value": [
        "medical-implant",
        "stimulation",
        "therapeutic"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "formFactor": {
      "value": [
        "implant"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "intendedUseCases": {
      "value": [
        "adjunctive therapy for drug-resistant partial-onset seizures (age 4+)",
        "AutoStim closed-loop stimulation triggered by rapid heart-rate increase"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "targetUsers": {
      "value": [
        "neurosurgeon",
        "neurologist",
        "patient-epilepsy"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "electrodes": {
    "totalChannels": {
      "value": 1,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "recordingChannels": {
      "value": 0,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "referenceChannels": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "electrodeType": {
      "value": [
        "cuff"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "material": {
      "value": [
        "platinum-iridium"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "positions1020": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "channels": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "requiresGel": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "requiresSaline": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "prepTimeMinutes": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "reusable": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "disposable": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "auxSensors": {
    "imu": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "imuAxes": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "accelerometer": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "gyroscope": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "magnetometer": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "ppg": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "ecg": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "emg": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "eog": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "edaGsr": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "temperature": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "respiration": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "microphone": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "eyeTracking": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "stimulation": {
    "capable": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "connectivity": {
    "protocols": {
      "value": [
        "proprietary-rf"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "bluetoothVersion": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "bluetoothProfiles": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "concurrentMode": {
      "value": "single-only",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "encryptionInTransit": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "pairingMethods": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "cloudSync": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "offlineRecording": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "power": {
    "sources": {
      "value": [
        "non-rechargeable"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "batteryLifeActiveHours": {
      "status": "unknown",
      "sources": [
        {
          "label": "Implant lifetime ~5–10 years per published reviews"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "chargingPort": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "chargingTimeMinutes": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "batteryReplaceable": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "notes": {
      "value": "Primary lithium cell; generator replacement surgery at end-of-life.",
      "status": "verified",
      "sources": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "physical": {
    "weightGrams": {
      "status": "unknown",
      "sources": [
        {
          "label": "v0 said 16.6 g; not pinned in primary sources"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "dimensions": {
      "status": "unknown",
      "sources": [
        {
          "label": "v0 listed 45 × 32 × 6.9 mm; not pinned in primary sources"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "materials": {
      "value": [
        "titanium"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "sizes": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "headCircumferenceCm": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "operatingTempC": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "compute": {
    "hasOnboardComputer": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "operatingSystems": {
      "value": [
        "custom-firmware"
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "primaryOs": {
      "value": "custom-firmware",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "edgeMlAccelerator": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "rootAccessLevel": {
      "value": "none",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "appSandbox": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "thirdPartyAppsAllowed": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "notes": {
      "value": "Onboard heart-rate detection algorithm gates AutoStim therapy.",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "software": {
    "apps": {
      "value": [
        {
          "name": "VNS Therapy Programming System (Model 3000)",
          "platforms": [
            "other"
          ],
          "free": false,
          "description": "Wireless wand + small tablet for clinician-side programming and patient-event review."
        }
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "mobileApp": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "cloudPlatform": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "offlineMode": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "subscriptionRequired": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "rawDataAccess": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "exportFormats": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "lslSupport": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "dataOwnership": {
      "value": "manufacturer",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "privacyPolicyUrl": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "sdk": {
    "hasSdk": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "docsUrl": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "openSource": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "languages": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "webBluetooth": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "rawSampleAccess": {
      "value": false,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "bciParadigms": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "thirdPartyIntegrations": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "capabilities": {
    "attentionFocus": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "meditationCalm": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "neurofeedback": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "meditationCoaching": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "sleepTracking": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "customCapabilities": {
      "value": [
        {
          "name": "AutoStim closed-loop seizure response",
          "description": "Onboard cardiac sensing detects unusually rapid heart-rate increases (a seizure surrogate) and triggers stimulation in response.",
          "evidenceLevel": "fda-cleared"
        },
        {
          "name": "Day/Night and Scheduled Programming",
          "description": "Patient-specific stimulation schedules track diurnal seizure patterns; clinician-set remote titration via Scheduled Programming.",
          "evidenceLevel": "fda-cleared"
        }
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "regulatory": {
    "fdaStatus": {
      "value": "pma",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637",
          "label": "FDA recall record — VNS Therapy SenTiva Generator Model 1000"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "ceMark": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "certifications": {
      "status": "unknown",
      "sources": [
        {
          "label": "v0 listed IEC-60601-1 / ISO-13485; not pinned in primary sources"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "prescriptionRequired": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "pediatricApproved": {
      "value": true,
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/",
          "label": "PMC — Evolution of the VNS Therapy System review"
        }
      ],
      "updatedAt": "2026-05-04"
    }
  },
  "pricing": {
    "msrp": {
      "status": "unknown",
      "sources": [
        {
          "label": "v0 said ~$30k hardware-only; implant pricing is hospital-negotiated, not publicly listed"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "currentPrice": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "subscription": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "buyUrls": {
      "value": [
        {
          "region": "global",
          "vendor": "LivaNova",
          "url": "https://www.livanova.com"
        }
      ],
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "warranty": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "returnPolicyDays": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "media": {
    "officialUrl": {
      "value": "https://www.livanova.com",
      "status": "verified",
      "sources": [
        {
          "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy",
          "label": "BusinessWire — LivaNova receives FDA approvals for SenTiva (2017-10-09)",
          "date": "2017-10-09"
        }
      ],
      "updatedAt": "2026-05-04"
    },
    "productPageUrl": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "editorial": {
    "pros": [
      "Smallest, lightest VNS generator on the market",
      "Closed-loop AutoStim seizure response",
      "Multi-decade clinical track record (Cyberonics → LivaNova)"
    ],
    "cons": [
      "Generator replacement surgery every ~8 years",
      "Voice alteration is a common side effect",
      "Closed manufacturer ecosystem"
    ],
    "bestFor": [
      "Drug-resistant epilepsy",
      "Treatment-resistant depression where TMS / ECT have failed"
    ],
    "notFor": [
      "Patients with implant contraindications",
      "Patients unwilling to accept voice-alteration risk"
    ],
    "comparableDevices": [
      "microtransponder-vivistim",
      "electrocore-gammacore-sapphire",
      "neuropace-rns"
    ]
  },
  "provenance": {
    "sources": [
      {
        "label": "BusinessWire — LivaNova SenTiva FDA approval (2017-10-09)",
        "url": "https://www.businesswire.com/news/home/20171009005303/en/LivaNova-Receives-FDA-Approvals-for-SenTiva-Device-and-Next-Generation-VNS-Therapy-Programming-System-for-Treatment-of-Epilepsy"
      },
      {
        "label": "FDA recall record — SenTiva Generator Model 1000",
        "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=176637"
      },
      {
        "label": "PMC — Evolution of the VNS Therapy System review",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8757869/"
      },
      {
        "label": "Medical Device Network — LivaNova launches SenTiva DUO",
        "url": "https://www.medicaldevice-network.com/news/livanova-sentiva-duo-epilepsy/"
      }
    ],
    "lastReviewedAt": "2026-05-06"
  }
}